Elanco Animal Health Inc

Company Snapshot
2500 Innovation Way
Greenfield, IN 46140
United States
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 9,740
https://www.elanco.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$1,606,700,000
$2,631,000,000
$2,498,000,000
Operating Income
($76,800,000)
$302,000,000
$384,000,000
Net Income
($560,100,000)
($472,000,000)
($78,000,000)
2020
Gross Profit
$1,606,700,000
Operating Income
($76,800,000)
Net Income
($560,100,000)
2021
Gross Profit
$2,631,000,000
Operating Income
$302,000,000
Net Income
($472,000,000)
2022
Gross Profit
$2,498,000,000
Operating Income
$384,000,000
Net Income
($78,000,000)
The above data on Elanco Animal Health Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Jeffrey Simmons
President, Chief Executive Officer and Director
$2,485,125
$10,200,031
$28,476
$12,713,632
Jeffrey Simmons
$12,713,632
President, Chief Executive Officer and Director
Todd Young
Executive Vice President and Chief Financial Officer
$1,114,416
$2,510,022
$30,046
$3,654,484
Todd Young
$3,654,484
Executive Vice President and Chief Financial Officer
Ellen de Brabander
Executive Vice President Innovation and Regulatory Affairs
$1,102,569
$1,678,048
$29,426
$2,810,043
Ellen de Brabander
$2,810,043
Executive Vice President Innovation and Regulatory Affairs
Ramiro Cabral
Executive Vice President and President of Elanco International
$944,372
$1,470,032
$28,446
$2,442,850
Ramiro Cabral
$2,442,850
Executive Vice President and President of Elanco International
Rajeev Modi
Executive Vice President U.S. Pet Health and Global Digital Transformation
$1,293,958
$900,017
$28,446
$2,222,421
Rajeev Modi
$2,222,421
Executive Vice President U.S. Pet Health and Global Digital Transformation
Elanco Animal Health Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us